Evidence map›Paper›PMID 38510021›Full record

ArticleHeliyon2024

iPro2L-DG: Hybrid network based on improved densenet and global attention mechanism for identifying promoter sequences.

Rufeng Lei, Jianhua Jia, Lulu Qin, Xin Wei

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rufeng LeiSchool of Information Engineering, Jingdezhen Ceramic University, Jingdezhen, 333403, China.
Jianhua JiaSchool of Information Engineering, Jingdezhen Ceramic University, Jingdezhen, 333403, China.
Lulu QinSchool of Information Engineering, Jingdezhen Ceramic University, Jingdezhen, 333403, China.
Xin WeiBusiness School, Jiangxi Institute of Fashion Technology, Nanchang, 330044, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The promoter is a key DNA sequence whose primary function is to control the initiation time and the degree of expression of gene transcription. Accurate identification of promoters is essential for understanding gene expression studies. Traditional sequencing techniques for identifying promoters are costly and time-consuming. Therefore, the development of computational methods to identify promoters has become critical. Since deep learning methods show great potential in identifying promoters, this study proposes a new promoter prediction model, called iPro2L-DG. The iPro2L-DG predictor, based on an improved Densely Connected Convolutional Network (DenseNet) and a Global Attention Mechanism (GAM), is constructed to achieve the prediction of promoters. The promoter sequences are combined feature encoding using C2 encoding and nucleotide chemical property (NCP) encoding. An improved DenseNet extracts advanced feature information from the combined feature encoding. GAM evaluates the importance of advanced feature information in terms of channel and spatial dimensions, and finally uses a Full Connect Neural Network (FNN) to derive prediction probabilities. The experimental results showed that the accuracy of iPro2L-DG in the first layer (promoter identification) was 94.10% with Matthews correlation coefficient value of 0.8833. In the second layer (promoter strength prediction), the accuracy was 89.42% with Matthews correlation coefficient value of 0.7915. The iPro2L-DG predictor significantly outperforms other existing predictors in promoter identification and promoter strength prediction. Therefore, our proposed model iPro2L-DG is the most advanced promoter prediction tool. The source code of the iPro2L-DG model can be found in https://github.com/leirufeng/iPro2L-DG.

Indexed as

DenseNetEncodingGlobal attention mechanismPromoterPromoter strength

Identifiers

PMID38510021
PMCPMC10950492

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.